Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Related Articles by Review for PubMed (Select 22832945)

1.

Mechanisms of bone fragility in a mouse model of glucocorticoid-treated rheumatoid arthritis: implications for insufficiency fracture risk.

Takahata M, Maher JR, Juneja SC, Inzana J, Xing L, Schwarz EM, Berger AJ, Awad HA.

Arthritis Rheum. 2012 Nov;64(11):3649-59. doi: 10.1002/art.34639.

2.

Biomechanical effects of inflammatory diseases on bone-rheumatoid arthritis as a paradigm.

Abdulghani S, Caetano-Lopes J, Canhão H, Fonseca JE.

Autoimmun Rev. 2009 Jul;8(8):668-71. doi: 10.1016/j.autrev.2009.02.021. Epub 2009 Feb 15. Review.

PMID:
19223022
3.

[Clinical features of fracture with glucocorticoid induced osteoporosis and rheumatoid arthritis].

Nampei A, Hashimoto J.

Clin Calcium. 2006 Nov;16(11):1866-70. Review. Japanese.

PMID:
17079854
4.

Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy.

Barnabe C, Hanley DA.

Semin Arthritis Rheum. 2009 Oct;39(2):116-22. doi: 10.1016/j.semarthrit.2008.04.004. Epub 2008 Jun 30. Review.

PMID:
18585759
5.

Glucocorticoid-induced bone fragility.

Lane NE, Yao W.

Ann N Y Acad Sci. 2010 Mar;1192:81-3. doi: 10.1111/j.1749-6632.2009.05228.x. Review.

PMID:
20392221
6.

The TNF-alpha transgenic mouse model of inflammatory arthritis.

Li P, Schwarz EM.

Springer Semin Immunopathol. 2003 Aug;25(1):19-33. Review.

PMID:
12904889
7.

Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy.

Aeberli D, Schett G.

Arthritis Res Ther. 2013 Mar 21;15(2):208. doi: 10.1186/ar4180. Review.

8.
9.

[Osteoporosis in rheumatoid arthritis--significance of alfacalcidol in prevention and therapy].

Schacht E.

Z Rheumatol. 2000;59 Suppl 1:10-20. Review. German.

PMID:
10769429
10.
11.

Strontium ranelate: a new paradigm in the treatment of osteoporosis.

Reginster JY, Deroisy R, Jupsin I.

Drugs Today (Barc). 2003 Feb;39(2):89-101. Review.

PMID:
12698204
12.

Bone composition: relationship to bone fragility and antiosteoporotic drug effects.

Boskey AL.

Bonekey Rep. 2013 Dec 4;2:447. doi: 10.1038/bonekey.2013.181. eCollection 2013. Review. Erratum in: Bonekey Rep. 2015;4:710.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk